KEY HIGHLIGHTS 1 - Pending Spin-Off Its Advance
Post# of 897
(Total Views: 151)
Posted On: 04/11/2018 8:48:51 PM
KEY HIGHLIGHTS
1 - Pending Spin-Off Its Advanced Molecular Services Group. The group includes CollabRx, Inc. Genomas, Inc. and Alethea Laboratories, Inc. To date, they have invested more than $20 million in these businesses. The Spin-Off expected to reduce the stockholder's equity perhaps meet the requirement of NASDAQ.
PENDING SPIN-OFF. Forecast to close during the first quarter 2018.
2 - Pending Acquisitions to acquire Jamestown hospital
3 - Won an appeal in the Eleventh Circuit Court of Appeals in a lawsuit filed by Rennova against CIGNA for failure to pay claims for laboratory services.
"This is an exciting development for us," said Seamus Lagan, Chief Executive Officer, "and allows us to push forward in our pursuit of the total amount of our original claims."
4 - $RNVA AMAZING!!! $4.00 STOCK PURCHASE AGREEMENT ON FEB 14, 2018.
Quote:Also, on February 14, 2018, Rennova entered into a Common Stock Purchase Agreement with two investors pursuant to which Rennova sold an aggregate of 200,000 Shares. The purchase price was $4.00 per share.
1 - Pending Spin-Off Its Advanced Molecular Services Group. The group includes CollabRx, Inc. Genomas, Inc. and Alethea Laboratories, Inc. To date, they have invested more than $20 million in these businesses. The Spin-Off expected to reduce the stockholder's equity perhaps meet the requirement of NASDAQ.
PENDING SPIN-OFF. Forecast to close during the first quarter 2018.
2 - Pending Acquisitions to acquire Jamestown hospital
3 - Won an appeal in the Eleventh Circuit Court of Appeals in a lawsuit filed by Rennova against CIGNA for failure to pay claims for laboratory services.
"This is an exciting development for us," said Seamus Lagan, Chief Executive Officer, "and allows us to push forward in our pursuit of the total amount of our original claims."
4 - $RNVA AMAZING!!! $4.00 STOCK PURCHASE AGREEMENT ON FEB 14, 2018.
Quote:Also, on February 14, 2018, Rennova entered into a Common Stock Purchase Agreement with two investors pursuant to which Rennova sold an aggregate of 200,000 Shares. The purchase price was $4.00 per share.
(1)
(0)